Cargando…

Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate

BACKGROUND: Nivolumab is a human IgG4 anti-programmed cell death protein-1 (PD-1) monoclonal antibody that works by augmenting the immune response against tumour cells. It has the potential of causing multiple autoimmune-related events, including cardiac. However, the real incidence and diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallegos, Cesia, Rottmann, Douglas, Nguyen, Vinh Q, Baldassarre, Lauren A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439394/ https://www.ncbi.nlm.nih.gov/pubmed/31020225 http://dx.doi.org/10.1093/ehjcr/yty149

Ejemplares similares

Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
por: Quail, Michael, et al.
Publicado: (2019)

Quantitative Assessment of Late Gadolinium Enhancement and Edema at Cardiac Magnetic Resonance in Low-Risk Myocarditis Patients
por: Monti, Caterina Beatrice, et al.
Publicado: (2022)

Late gadolinium enhancement characteristics in giant cell myocarditis
por: Yang, Shujuan, et al.
Publicado: (2021)

Comparison of 3D and 2D late gadolinium enhancement magnetic resonance imaging in patients with acute and chronic myocarditis
por: Polacin, M., et al.
Publicado: (2020)

Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation
por: Nguyen, Andrew T., et al.
Publicado: (2022)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance
por: Steadman, Christopher D, et al.
Publicado: (2009)

A case of coronavirus disease 2019 vaccine‐related myocarditis with late gadolinium enhancement on cardiac magnetic resonance imaging persisting over acute phase
por: Konno, Ai, et al.
Publicado: (2022)

Association between ECG parameters and late gadolinium enhancement along the course of myocarditis
por: Károlyi, Mihály, et al.
Publicado: (2023)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity
por: Higgins, Angela Y., et al.
Publicado: (2021)

Gadolinium changes detected on cardiovascular magnetic resonance imaging following COVID-19 vaccine-related myocarditis in adolescents
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Association of QRS-T angle and Late Gadolinium Enhancement in patients with a Clinical Suspicion of Myocarditis
por: Jensen, C.J., et al.
Publicado: (2021)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
por: Strijack, Bradford, et al.
Publicado: (2008)

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
por: Lopez, Javier E, et al.
Publicado: (2009)

Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study
por: Treiber, Julia, et al.
Publicado: (2023)

Prognostic significance of regional edema and quantitative assessment of late gadolinium enhancement in patients with acute myocarditis
por: Vermes, Emmanuelle, et al.
Publicado: (2011)

Short-term outcome of late gadolinium changes detected on cardiovascular magnetic resonance imaging following coronavirus disease 2019 Pfizer/BioNTech vaccine-related myocarditis in adolescents
por: Krupickova, Sylvia, et al.
Publicado: (2023)

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance
por: Kirk, Paul, et al.
Publicado: (2011)

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
por: Freed, Benjamin H, et al.
Publicado: (2012)

A comparison of late gadolinium enhancement magnetic resonance imaging and left atrial endocardial voltage
por: Harrison, James, et al.
Publicado: (2013)

Prediction of gaps in atrial ablation lesion sets by late gadolinium enhancement magnetic resonance imaging
por: Harrison, James, et al.
Publicado: (2013)

Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy
por: Ganigara, Madhusudan, et al.
Publicado: (2016)

Late gadolinium enhancement by cardiovascular magnetic resonance provides prognostic information in symptomatic alcoholic cardiomyopathy
por: Xiangli, Wei
Publicado: (2015)

Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis
por: Sano, Makoto, et al.
Publicado: (2014)

Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar
por: Fahmy, Ahmed S., et al.
Publicado: (2018)

Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
por: Erley, Jennifer, et al.
Publicado: (2019)

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy
por: Schelbert, Erik B., et al.
Publicado: (2017)

Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes
por: Domenech-Ximenos, B., et al.
Publicado: (2020)

Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
por: Whitaker, John, et al.
Publicado: (2021)

Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
por: Gangadharakaimal, Harikrishnan, et al.
Publicado: (2023)

Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation
por: Holtackers, Robert J., et al.
Publicado: (2019)

Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging
por: Huang, Y. Jessica, et al.
Publicado: (2016)

Cardiovascular Magnetic Resonance in Myocarditis
por: Polte, Christian L., et al.
Publicado: (2022)

The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images
por: Naruse, Yoshihisa, et al.
Publicado: (2011)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Prognostic utility of late gadolinium enhancement on cardiac magnetic resonance in cardiac amyloidosis: a meta-analysis
por: Raina, Sameer, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8i0mm8f1aoqesmp36i4p01soph